| Entire participants (3376) | Subjects included (n = 3159) | Subjects excluded (n = 217) | P value |
---|---|---|---|---|
Male (n, %) | 1918 (56.81%) | 1793 (56.76%) | 125 (57.60%) | 0.83 |
Age, y (mean ± SD) | 56.67 ± 10.33 | 56.17 ± 9.88 | 64.05 ± 13.48 | < 0.0001 |
Previous history of disease | ||||
 hypertension(n, %) | 1178 (34.89%) | 1094 (34.63%) | 84 (38.71%) | 0.24 |
 diabetes(n, %) | 352 (10.43%) | 321(10.16%) | 31 (14.29%) | 0.07 |
 hyperlipidemia(n, %) | 566 (16.77%) | 525 (16.62%) | 41 (18.89%) | 0.40 |
Family history of stroke (n,%) | 82 (2.43%) | 81 (2.56%) | 1 (0.46%) | 0.0627 |
Smoking(n, %) | 666 (19.73%) | 634 (20.07%) | 32 (14.75%) | 0.0636 |
BMI, kg/m2 (mean ± SD) | 24.93 ± 3.25 | 24.93 ± 3.22 | 24.93 ± 3.65 | 0.83 |
RNFL thickness, micron (mean ± SD) | 101.89 ± 10.53 | 102.14 ± 10.37 | 98.16 ± 12.01 | < 0.0001 |
CRAE, micron (mean ± SD) |  | 153.87 ± 19.72 |  |  |
CRVE, micron (mean ± SD) |  | 232.73 ± 25.75 |  |  |
AVR(mean ± SD) |  | 0.67 ± 0.11 |  |  |